Qinqin Deng

Qinqin Deng

Auto-generated profile, based on publicly available information

Qinqin Deng

Eye Institute, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, 430060, Hubei, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
DXDongchang Xiao
Dongchang Xiao
QDQinqin Deng
Qinqin Deng
YGYanan Guo
Yanan Guo
XHXiuting Huang
Xiuting Huang
MZMin Zou
Min Zou
MXMengqing Xiang
Mengqing Xiang
Generation of sensory ganglion organoids and retinal ganglion cells from fibroblasts for research and therapeutic applications.

1 September 2021 in Experimental Eye Research
Verified
Journal Article
Open access
DLDongmei Liu
Dongmei Liu
QDQinqin Deng
Qinqin Deng
XLXinlan Lei
Xinlan Lei
WLWei Lu
Wei Lu
QZQingqing Zhao
Qingqing Zhao
YSYin Shen
Yin Shen
Activation of bone morphogenetic protein (BMP) 4 signaling promotes the survival of retinal ganglion cell (RGC) after acute injury. Chordin-like 1 (CHRDL1) is an endogenous BMP antagonist. In this study, we researched whether CHRDL1 was involved in BMP4 signaling and regulation of RGC degeneration in a mouse model of glaucoma. Magnetic microbeads were intracameral injected to induce experimental glaucoma in a mouse model. A recombinant adeno-associated virus (rAAV) system was designed for overexpression of BMP4 or CHRDL1 in mouse retina. Immunohistochemistry and hematoxylin-eosin (HE) stains were performed to identify changes in retinal morphology. Electroretinogram (ERG) recordings were used to assess changes in visual function. The mRNA expression levels of Bmp4 and its downstream BMPRIa, small mothers against decapentaplegic 1 (Smad1), were significantly upregulated in retinas with glaucoma. RGC survival was significantly enhanced in the beads + AAV-BMP4 group and significantly reduced in the beads + AAV-CHRDL1 group, compared with the beads + AAV-EGFP group. Similar results were observed in retinal explant culture in vitro. Consistent with these findings, the photopic negative response (PhNR)responses in ERG, which indicate RGC function, were restored in mice overexpressing BMP4, whereas a-wave and b-wave responses were not. Activation of CHRLD1 inhibited Smad1/5/8 phosphorylation and exacerbated RGC damage. The expression of Glial fibrillary acidic protein (GFAP) was decreased significantly in beads + AAV-BMP4 group. BMP4 promoted RGC survival and visual function in an experimental glaucoma model. Activation of CHRDL1 exaggerated RGC degeneration by inhibiting the BMP4/Smad1/5/8 pathway. The mechanism of BMP4/Smad1/5/8 pathway may be related to the inhibition of glial cell activation. Our studies suggested that BMP4 and CHRLD1 might serve as therapeutic targets in glaucoma.